Neurocrine Biosciences Inc (NASDAQ:NBIX)

79.40
Delayed Data
As of 4:00pm ET
 +1.22 / +1.56%
Today’s Change
41.76
Today|||52-Week Range
92.98
+2.33%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close78.18
Today’s open78.00
Day’s range77.01 - 80.42
Volume600,025
Average volume (3 months)884,268
Market cap$8.3B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+0.61%
Earnings growth (this year)+88.39%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+977.51%
P/E ratioNM
Price/Sales42.29
Price/Book22.05

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp+0.72+1.54%
TECHBio-Techne Corp+0.59+0.39%
----
BLUEbluebird bio Inc0.000.00%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$161.6M
Annual profit (last year)-$142.5M
Net profit margin-88.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Kevin Charles Gorman
Chief Financial Officer
Matthew C. Abernethy
Corporate headquarters
San Diego, California

Forecasts